Glasgow, United Kingdom

Susane De La Luna


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susane De La Luna: Innovator in Cell Cycle Regulation

Introduction

Susane De La Luna is a prominent inventor based in Glasgow, GB. She has made significant contributions to the field of cell biology, particularly in understanding the mechanisms that regulate cell cycle progression. Her innovative work has led to the development of a patent that showcases her expertise and dedication to scientific advancement.

Latest Patents

Susane holds a patent titled "Assay for a putative regulator of cell cycle progression." This invention provides nuclear localization signals derived from the DP-3 and E2F-1 transcription factors. The patent outlines the use of these signals in assays designed to identify regulators of cell cycle progression. The assays involve directing a marker gene to the nucleus and determining whether the nuclear localization of the marker is disrupted by the presence of a putative regulator.

Career Highlights

Throughout her career, Susane has demonstrated a strong commitment to research and innovation. Her work has not only advanced scientific knowledge but has also paved the way for potential applications in therapeutic interventions. She is currently associated with Prolifix Limited, where she continues to contribute to groundbreaking research in her field.

Collaborations

Susane collaborates with Nicholas D La Thangue, a fellow researcher who shares her passion for exploring the intricacies of cell biology. Their partnership has fostered a productive environment for scientific inquiry and innovation.

Conclusion

Susane De La Luna is a remarkable inventor whose work in cell cycle regulation has the potential to impact various scientific and medical fields. Her dedication to research and collaboration exemplifies the spirit of innovation that drives progress in the life sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…